Cargando…

Myeloma Bone Disease: The Osteoblast in the Spotlight

Lytic bone disease remains a life-altering complication of multiple myeloma, with up to 90% of sufferers experiencing skeletal events at some point in their cancer journey. This tumour-induced bone disease is driven by an upregulation of bone resorption (via increased osteoclast (OC) activity) and a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrews, Rebecca E., Brown, Janet E., Lawson, Michelle A., Chantry, Andrew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432062/ https://www.ncbi.nlm.nih.gov/pubmed/34501423 http://dx.doi.org/10.3390/jcm10173973

Ejemplares similares

New agents in the Treatment of Myeloma Bone Disease
por: Ring, Elizabeth S., et al.
Publicado: (2017)

The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma
por: Stewart, Georgia, et al.
Publicado: (2021)

Diagnosis and Treatment of Bone Disease in Multiple Myeloma: Spotlight on Spinal Involvement
por: Tosi, Patrizia
Publicado: (2013)

Osteoblast suppression in multiple myeloma bone disease
por: Adamik, Juraj, et al.
Publicado: (2018)

NOD/SCID-GAMMA Mice Are an Ideal Strain to Assess the Efficacy of Therapeutic Agents Used in the Treatment of Myeloma Bone Disease
por: Lawson, Michelle A., et al.
Publicado: (2015)

Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models
por: Paton‐Hough, Julia, et al.
Publicado: (2018)

Bone Pain in Multiple Myeloma (BPMM)—A Protocol for a Prospective, Longitudinal, Observational Study
por: Diaz-delCastillo, Marta, et al.
Publicado: (2021)

Spotlight on ixazomib: potential in the treatment of multiple myeloma
por: Muz, Barbara, et al.
Publicado: (2016)

The Metabolic Features of Osteoblasts: Implications for Multiple Myeloma (MM) Bone Disease
por: Lungu, Oxana, et al.
Publicado: (2023)

ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo
por: Lath, Darren L., et al.
Publicado: (2018)

Spotlight on elotuzumab in the treatment of multiple myeloma: the evidence to date
por: Weisel, Katja
Publicado: (2016)

Targeting Tumour-Initiating Cells with TRAIL Based Combination Therapy Ensures Complete and Lasting Eradication of Multiple Myeloma Tumours In Vivo
por: Vitovski, Srdjan, et al.
Publicado: (2012)

Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma
por: Morabito, Fortunato, et al.
Publicado: (2021)

Epigenetic‐Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone Disease
por: Adamik, Juraj, et al.
Publicado: (2019)

Osteoblast inhibition by chemokine cytokine ligand3 in myeloma-induced bone disease
por: Fu, Rong, et al.
Publicado: (2014)

Roles of LINC01473 and CD74 in osteoblasts in multiple myeloma bone disease
por: Peng, Fengping, et al.
Publicado: (2022)

Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma
por: Iannozzi, Nicolas Thomas, et al.
Publicado: (2022)

Myeloma bone disease: Pathophysiology and management
por: Silbermann, Rebecca, et al.
Publicado: (2013)

PGC-1s in the Spotlight with Parkinson’s Disease
por: Piccinin, Elena, et al.
Publicado: (2021)

HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse Models
por: Tazzyman, Simon, et al.
Publicado: (2023)

Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy
por: Keyel, Michelle E, et al.
Publicado: (2018)

Osteoblast Dysfunction in Non-Hereditary Sclerosing Bone Diseases
por: Giardullo, Liberato, et al.
Publicado: (2021)

Spotlight on… Janet K. Jansson
por: Jansson, Janet K.
Publicado: (2016)

Integrins in the Spotlight of Cancer
por: Bianconi, Daniela, et al.
Publicado: (2016)

Spotlight on fundus autofluorescence
por: Calvo-Maroto, Ana M, et al.
Publicado: (2018)

Spotlight on math anxiety
por: Luttenberger, Silke, et al.
Publicado: (2018)

Spotlight on reticular pseudodrusen
por: Rabiolo, Alessandro, et al.
Publicado: (2017)

Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts
por: Faict, Sylvia, et al.
Publicado: (2018)

Spotlight on Digital Eye Strain
por: Mylona, Ioanna, et al.
Publicado: (2023)

Myeloma cells suppress osteoblasts through sclerostin secretion
por: Colucci, S, et al.
Publicado: (2011)

Pathways to Parkinson’s disease: a spotlight on 14-3-3 proteins
por: Giusto, E., et al.
Publicado: (2021)

Spotlight on CYP4B1
por: Röder, Annika, et al.
Publicado: (2023)

Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts
por: Shupp, Alison B., et al.
Publicado: (2018)

Osteoblast-Osteoclast Communication and Bone Homeostasis
por: Kim, Jung-Min, et al.
Publicado: (2020)

Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability
por: Chiu, Martina, et al.
Publicado: (2020)

Spotlight on the Disc-Damage Likelihood Scale (DDLS)
por: Cheng, Kelvin K W, et al.
Publicado: (2021)

Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers
por: D’Avola, Annalisa, et al.
Publicado: (2023)

Bone Disease in Multiple Myeloma: Biologic and Clinical Implications
por: Bernstein, Zachary S., et al.
Publicado: (2022)

Endoglin in the Spotlight to Treat Cancer
por: González Muñoz, Teresa, et al.
Publicado: (2021)

Neurodegenerative Disorders: Spotlight on Sphingolipids
por: Mandik, Frida, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lpmsvvhu0jbt148r1l5j0hd39a